FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068503 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 03/06/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Single point acupuncture treatment for acute headache 
Scientific Title of Study   Effect of single point acupuncture for headache in acute care: a single centre, prospective randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pavan B Mulimani 
Designation  Student 
Affiliation  Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire 
Address  Department of Acupuncture and Meridian studies, Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire, Belthangady

Dakshina Kannada
KARNATAKA
574240
India 
Phone  9380876052  
Fax    
Email  pavansdpbp1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Geetha B Shetty 
Designation  Professor, Dean  
Affiliation  Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire 
Address  Department of Acupuncture and Meridian studies, Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire Belthangady

Dakshina Kannada
KARNATAKA
574240
India 
Phone  09449714767  
Fax    
Email  gbsujire@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pavan B Mulimani 
Designation  Student 
Affiliation  SDM college of naturopathy and yogic sciences 
Address  Department of Acupuncture and Meridian studies, Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire, Belthangady

Dakshina Kannada
KARNATAKA
574240
India 
Phone  9380876052  
Fax    
Email  pavansdpbp1@gmail.com  
 
Source of Monetary or Material Support  
Sri Dharmasthala Manjunatheshwara Yoga and Naturecure hospital Shanthivana 
 
Primary Sponsor  
Name  Dr Pavan B Mulimani 
Address  Department of Acupuncture and Meridian studies, Sri Dharmasthala Manjunatheshwara College of Naturopathy and Yogic Sciences, Ujire Belthangady, Karnataka 574240 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pavan B Mulimani  Sri Dharmasthala Manjunatheshwara Yoga and Naturecure hospital Shanthivana  Department of Natural Therapeutics, Shanthivana, Dharmasthala
Dakshina Kannada
KARNATAKA 
09380876052

pavansdpbp1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Dharmasthala Manjunatheshawara College of Naturopathy and Yogic sciences Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R51||Headache,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Sham acupuncture   Patients in the control group will be receiving predefined distant non-acupuncture points bilaterally and superficially using fine needles. Physicians avoided “de qi” and manual stimulation of the needles. 
Intervention  Single point acupuncture  Acupuncture patients will be treated at “LI-10” point bilaterally. We instructed physicians to achieve “de qi” (an irradiating feeling considered to be indicative of effective needling) if possible and to stimulate needles manually at least once during each session. ‘LI-10’ acupuncture point location: 2 t-sun below the Quchi (LI 11) Duration: 20 minutes 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1) Met current International Headache Society (IHS) and International Classification of Headache Disorders (ICHD-2) criteria for migraine (with or without aura) at time of entry into the study
2) Who reported an average of at least two headaches per month are eligible.
 
 
ExclusionCriteria 
Details  1) Participants who are taking more than three medications (including over-the-counter) specifically for migraine at the time of interview, or
2) Had failed triptan therapy in the past.
3) History of any current co-morbid illness.
4) Onset of headache disorder less than one year before or at age 50 or older
5) Pregnancy
6) Malignancy
7) Cluster headache (IHS code 3)
8) Suspicion that headache disorder had specific aetiology (IHS code 5-11)
9) Cranial neuralgias (IHS code 12); and
10) Acupuncture treatment in the previous 12 months.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Visual analogue scale (VAS)  Baseline and immediately after the intervention 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   14/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Migraine and tension-type headache give rise to notable health, clinically, migraine is characterised by hemicranial throbbing pain, which may or may not be accompanied by vomiting, nausea, photophobia (heightened sensitivity to light), phonophobia (heightened sensitivity to sound), and temporary neurological symptoms
Tension-type headache is essentially defined as bilateral headache of a pressing or tightening quality without a known medical cause. Tension-type headache is classified as episodic if it occurs on less than 15 days a month and as chronic if it occurs more often
Hence due to the adverse effects of the drug’s taken people are opting for non-pharmacological interventions, any action that does not use medication and is intended to improve an individual’s health is referred to as non-pharmacologic interventions (NPI). This includes complementary and alternative medicine (CAM) techniques, which have become more and more common among headache sufferers in recent years, non-pharmacological treatments are typically well tolerated and can be helpful in helping patients control their pain. A expanding array of non-pharmacological therapeutic modalities have demonstrated encouraging efficacy, such as acupuncture, psychotherapy, physiotherapy and non-invasive or invasive neuromodulation.
Acupuncture is one of the NPI, which is chosen widely due to its high efficacy and less side effects. The World Health Organization defines acupuncture (zhen) in their 2007 as: “the insertion of needles into humans or animals for remedial purposes or its methods”. (19) Anecdotal studies have shown that acupuncture can be helpful in managing the headache. 
So, the present study was designed to assess the influence of single point acupuncture on headache.
 
Close